Related Experiment Video
Updated: Jul 26, 2025

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Horsfielenigans A and B, Two Rearranged Lignans with Anti-Inflammatory Effects from Horsfieldia kingii
Xian-Huan Zhang1, Zhao Lu1, Zhi-Yuan Li2
1School of Chemistry and Chemical Engineering, Yunnan Normal University, Kunming, 650050, P. R. China.
New lignans from Horsfieldia kingii, horsfielenigans A and B, show potential in reducing nitric oxide (NO) production in immune cells. These compounds may offer therapeutic benefits for inflammatory conditions.
Area of Science:
- Natural Product Chemistry
- Pharmacology
Background:
- Horsfieldia kingii is a plant source of bioactive compounds.
- Lignans are a class of natural products with diverse biological activities.
- Nitric oxide (NO) plays a role in inflammatory processes.
Purpose of the Study:
- To isolate and characterize lignans from Horsfieldia kingii.
- To evaluate the in vitro bioactivity of isolated lignans against nitric oxide production.
Main Methods:
- Extraction of plant material using 70% aqueous acetone.
- Isolation and purification of compounds using spectroscopic techniques.
- In vitro bioactivity assay using LPS-activated RAW264.7 macrophages to measure NO production.
Main Results:
- Seven lignans were isolated, including three new compounds.
- Horsfielenigans A (1) and B (2) possess a rare β-benzylnaphthalene skeleton.
- Compounds 1 and 2 demonstrated significant inhibition of nitric oxide production with IC50 values of 7.3 μM and 9.7 μM, respectively.
Conclusions:
- Horsfieldia kingii yielded novel lignans with a unique chemical structure.
- Horsfielenigans A and B exhibit promising anti-inflammatory potential by inhibiting NO production.
- These findings suggest potential therapeutic applications for these lignans in managing inflammation.
More Related Videos
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids